Approved anti-alzheimer’s disease drugs, including acetylcholinesterase (AChE) inhibitors like tacrine, donepezil, and N-methyl-D-aspartate (NMDA) receptor antagonists, can alleviate symptoms, particularly in the early to moderate stages of the disease. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.